International Study Examines Colorectal Cancer Screening Accuracy in Young Adults

New international research evaluates fecal test accuracy for colorectal cancer in adults under 50, suggesting age-adjusted thresholds could improve early and precise diagnosis.

International Study Examines Colorectal Cancer Screening Accuracy in Young Adults
Photo-illustration WireIsrael: AI Generated

Amid a concerning global rise in colorectal cancer cases among younger adults, new international research is raising questions about the efficacy of a common diagnostic test for this demographic. Researchers from the University of Nottingham, in collaboration with academic bodies in the United Kingdom and the USA, examined the accuracy of the fecal immunochemical test, which detects microscopic traces of blood in stool, among individuals under the age of 50.

The findings suggest that the standard threshold value used to interpret the test may not be equally suitable for all age groups, indicating a potential need for calibration to better identify suspicious cases among young people.

Findings on Younger Patient Screening

Family physicians frequently use fecal immunochemical tests to screen patients presenting with suspicious symptoms. A negative result indicates a very low risk without the need for immediate follow-up, whereas a reading of ten or higher prompts an urgent referral for an invasive diagnostic procedure such as a colonoscopy. Researchers reviewed 12 studies encompassing more than 69,000 symptomatic participants under the age of 50, discovering that only about 0.35 percent—or roughly one in 300—were ultimately diagnosed with colorectal cancer.

By comparison, the likelihood of detecting colorectal cancer among individuals over the age of 50 was three to seven times higher than in younger cohorts. Investigators determined that applying a uniform threshold across all ages could lead to an excess of young patients undergoing invasive colonoscopies to diagnose a single case of cancer. Adjusting the cutoff value according to patient age could help pinpoint high-risk individuals more accurately, reduce unnecessary procedures, and accelerate diagnosis when warranted, though further research is required before clinical guidelines are altered.

The Need for Customized Thresholds

Professor David Humes from the University of Nottingham, a senior author of the study, explained that this marks the first time existing evidence on stool tests for symptomatic patients has been synthesized with a specific focus on performance by age. He emphasized that future investigations must determine the optimal threshold for individuals under 50, explore how to integrate the test into personalized risk prediction models, and identify alternative factors that might cause elevated fecal test results in younger populations.

Angie Davies, president of the US advocacy organization Fight Colorectal Cancer, which contributed to the research, noted that early-onset colorectal cancer is increasing worldwide. She stated that the consolidated international data demonstrates that a one-size-fits-all threshold is inadequate across different age brackets, and that subsequent steps will foster more precise, tailored diagnostics for patients under 50.

Related News